Charles River Laboratories
297 hedge funds and large institutions have $3.52B invested in Charles River Laboratories in 2016 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 119 increasing their positions, 108 reducing their positions, and 30 closing their positions.
102% more call options, than puts
Call options by funds: $955K | Put options by funds: $472K
53% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 30
10% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 108
5% more funds holding
Funds holding: 284 → 297 (+13)
0.14% less ownership
Funds ownership: 97.79% → 97.64% (-0.14%)
9% less capital invested
Capital invested by funds: $3.85B → $3.52B (-$330M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$32.5M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$31.9M |
| 3 |
D.E. Shaw & Co
New York
|
+$20.2M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$19.3M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$18.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$61M |
| 2 |
O
OppenheimerFunds
New York
|
-$40.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$38.4M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$28.8M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$22M |
CRL Hedge Fund Activity: Q4 2016 in Review
297 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2016, worth a combined $3.52B — down 8.6% from $3.85B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new CRL positions and 30 closed out — a net gain of 16 holders — while 119 added to existing stakes and 108 trimmed.
The largest buyer was Marshall Wace, adding an estimated $32.5M. The largest seller was Acadian Asset Management, cutting an estimated $61M.
- 297 institutional investors held Charles River Laboratories (CRL) as of Q4 2016, up from 284 in Q3 2016.
- Funds reported $3.52B of Charles River Laboratories stock for Q4 2016, down 8.6% quarter-over-quarter.
- 46 funds opened new Charles River Laboratories positions in Q4 2016 and 30 closed out, a net change of +16 holders.
- The largest Charles River Laboratories buyer in Q4 2016 was Marshall Wace, an estimated $32.5M added.
- The largest Charles River Laboratories seller in Q4 2016 was Acadian Asset Management, an estimated $61M sold.
Based on aggregated 13F filings for Q4 2016.